The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Interleukin-6 Family Cytokines
Open accessAbstract
The interleukin (IL)-6 family cytokines is a group of cytokines consisting of IL-6, IL-11, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin 1 (CT-1), cardiotrophin-like cytokine (CLC), and IL-27. They are grouped into one family because the receptor complex of each cytokine contains two (IL-6 and IL-11) or one molecule (all others cytokines) of the signaling receptor subunit gp130. IL-6 family cytokines have overlapping but also distinct biologic activities and are involved among others in the regulation of the hepatic acute phase reaction, in B-cell stimulation, in the regulation of the balance between regulatory and effector T cells, in metabolic regulation, and in many neural functions. Blockade of IL-6 family cytokines has been shown to be beneficial in autoimmune diseases, but bacterial infections and metabolic side effects have been observed. Recent advances in cytokine blockade might help to minimize such side effects during therapeutic blockade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Self-citationHirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · cited 6×
“Interestingly, the cytoplasmic portion of IL-6R was not needed for IL-6 signaling and, curiously, a truncated IL-6R lacking cytoplasmic and transmembrane domain in the presence of IL-6 was still able to bind to and NH2 COOH Site 1 S S S S IL-6 A B IL-6R S S NH2 Ig domain ≈ 90 aa COOH Transmembrane domain ≈ 28 aa Cytop…”
BackgroundResultInfluentialBlastocyst implantation depends on maternal expression of leukaemia inhibitory factor
Stewart, C. L., Kaspar, P., Brunet, L. J., Bhatt, H., Gadi, I., Köntgen, F., & Abbondanzo, S. J. (1992) · Nature · doi:10.1038/359076a0 · Cited by 2,034
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · cited 1×
“In mice fed a high-fat diet, selective blockade of IL-6 trans-signaling prevented the inflammatory infiltration of macrophages into adipose tissue (Kraakman et al. 2015) without leading to increased insulin resistance or decreased glucose tolerance, which had been observed in IL-62/2 mice (Matthews…”
BackgroundGauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationThe biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Waldmann, T. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1901 · Cited by 1,178
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., & Kishimoto, T. (1988) · Science · doi:10.1126/science.3136546 · Cited by 1,060
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
Dillon, S. R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S. R., Haugen, H. S., Maurer, M., Harder, B., Johnston, J., et al. (2004) · Nature Immunology · doi:10.1038/ni1084 · Cited by 1,015
Gearing, D. P., Comeau, M. R., Friend, D. J., Gimpel, S. D., Thut, C. J., McGourty, J., Brasher, K. K., King, J. A., Gillis, S., Mosley, B., et al. (1992) · Science · doi:10.1126/science.1542794 · Cited by 889
IL-6 pathway in the liver: From physiopathology to therapy
Schmidt-Arras, D., & Rose-John, S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.004 · Cited by 881
Self-citationLesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.009 · Cited by 862
Self-citationLütticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., et al. (1994) · Science · doi:10.1126/science.8272872 · Cited by 814 · cited 3×
“During the 1990s, intracellular signaling induced by activated gp130 was recognized to be mainly mediated by JAKs constitutively associated with the cytoplasmic portion of gp130, which led to the recruitment and activation of signal transducers and activators of transcription (STATs), which on phosphorylation by JAKs…”
BackgroundInfluentialSoluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
Self-citationTargeting key proximal drivers of type 2 inflammation in disease
Gandhi, N. A., Bennett, B. L., Graham, N. M. H., Pirozzi, G., Stahl, N., & Yancopoulos, G. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd4624 · Cited by 766
WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27
Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H., McClanahan, T. K., de Waal Malefyt, R., & Kastelein, R. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2225 · Cited by 695
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Self-citationGabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60250-0 · Cited by 672
Paul, S. R., Bennett, F., Calvetti, J. A., Kelleher, K., Wood, C. R., O'Hara, R. M., Leary, A. C., Sibley, B., Clark, S. C., & Williams, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7512 · Cited by 652
Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex
Boulanger, M. J., Chow, D.-C., Brevnova, E. E., & Garcia, K. C. (2003) · Science · doi:10.1126/science.1083901 · Cited by 642
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Self-citationHaemopoietic receptors and helical cytokines
Bazan, J. F. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90139-z · Cited by 638
Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor
Stöckli, K. A., Lottspeich, F., Sendtner, M., Masiakowski, P., Carroll, P., Götz, R., Lindholm, D., & Thoenen, H. (1989) · Nature · doi:10.1038/342920a0 · Cited by 616
Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.
Gearing, D. P., Thut, C. J., VandeBos, T., Gimpel, S. D., Delaney, P. B., King, J., Price, V., Cosman, D., & Beckmann, M. P. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07833.x · Cited by 590
Gearing, D. P., Gough, N. M., King, J. A., Hilton, D. J., Nicola, N. A., Simpson, R. J., Nice, E. C., Kelso, A., & Metcalf, D. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02742.x · Cited by 574
Disruption of the CNTF gene results in motor neuron degeneration
Masu, Y., Wolf, E., Holtmann, B., Sendtner, M., Brem, G., & Thoenen, H. (1993) · Nature · doi:10.1038/365027a0 · Cited by 558
Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.
Pennica, D., King, K. L., Shaw, K. J., Luis, E., Rullamas, J., Luoh, S. M., Darbonne, W. C., Knutzon, D. S., Yen, R., & Chien, K. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1142 · Cited by 554
A bioactive designer cytokine for human hematopoietic progenitor cell expansion
Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P. G., Kallen, K.-J., Wollmer, A., Grötzinger, J., & Rose-John, S. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-142 · Cited by 530
Self-citationADAM17: a molecular switch to control inflammation and tissue regeneration
Scheller, J., Chalaris, A., Garbers, C., & Rose-John, S. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.005 · Cited by 526
Self-citationInterleukin-6: Biology, signaling and strategies of blockade
Schaper, F., & Rose-John, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.004 · Cited by 509
Self-citationThe soluble interleukin‐6 receptor is generated by shedding
Mülberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 506
Self-citationZilberstein, A., Ruggieri, R., Korn, J. H., & Revel, M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04531.x · Cited by 487
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature · doi:10.1038/nature07475 · Cited by 477
Robb, L., Li, R., Hartley, L., Nandurkar, H. H., Koentgen, F., & Begley, C. G. (1998) · Nature Medicine · doi:10.1038/nm0398-303 · Cited by 468
Three-dimensional structure of a genetically engineered variant of porcine growth hormone.
Abdel-Meguid, S. S., Shieh, H. S., Smith, W. W., Dayringer, H. E., Violand, B. N., & Bentle, L. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6434 · Cited by 458
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T., & Yoshizaki, K. (2000) · Blood · doi:10.1182/blood.v95.1.56 · Cited by 441
Purification, Cloning, and Expression of Ciliary Neurotrophic Factor (CNTF)
Lin, L.-F. H., Mismer, D., Lile, J. D., Armes, L. G., Butler, E. T., Vannice, J. L., & Collins, F. (1989) · Science · doi:10.1126/science.2587985 · Cited by 417
Plasticity and cross-talk of Interleukin 6-type cytokines
Garbers, C., Hermanns, H. M., Schaper, F., Müller-Newen, G., Grötzinger, J., Rose-John, S., & Scheller, J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.001 · Cited by 400
Self-citationDual Oncostatin M (OSM) Receptors
Mosley, B., De Imus, C., Friend, D., Boiani, N., Thoma, B., Park, L. S., & Cosman, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32635 · Cited by 386
DeChiara, T. M., Vejsada, R., Poueymirou, W. T., Acheson, A., Suri, C., Conover, J. C., Friedman, B., McClain, J., Pan, L., Stahl, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90172-8 · Cited by 379
Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins
Mackiewicz, A., Schooltink, H., Heinrich, P. C., & Rose-John, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.6.2021 · Cited by 370
Self-citationLethal tuberculosis in interleukin-6-deficient mutant mice
Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K., Kopf, M., & Kaufmann, S. H. (1997) · Infection and Immunity · doi:10.1128/iai.65.11.4843-4849.1997 · Cited by 358
Released Form of CNTF Receptor α Component as a Soluble Mediator of CNTF Responses
Davis, S., Aldrich, T. H., Ip, N. Y., Stahl, N., Scherer, S., Farruggella, T., DiStefano, P. S., Curtis, R., Panayotatos, N., Gascan, H., et al. (1993) · Science · doi:10.1126/science.7681218 · Cited by 350
Structural analysis of the sequence coding for an inducible 26‐kDa protein in human fibroblasts
HAEGEMAN, G., CONTENT, J., VOLCKAERT, G., DERYNCK, R., TAVERNIER, J., & FIERS, W. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09931.x · Cited by 337
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
Matthews, V. B., Allen, T. L., Risis, S., Chan, M. H. S., Henstridge, D. C., Watson, N., Zaffino, L. A., Babb, J. R., Boon, J., Meikle, P. J., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1865-y · Cited by 334
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22433 · Cited by 333
Self-citationChalaris, A., Rabe, B., Paliga, K., Lange, H., Laskay, T., Fielding, C. A., Jones, S. A., Rose-John, S., & Scheller, J. (2007) · Blood · doi:10.1182/blood-2007-01-067918 · Cited by 329
Self-citationIL-6 biology: implications for clinical targeting in rheumatic disease
Calabrese, L. H., & Rose-John, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.127 · Cited by 328
Self-citationMaintenance of Pluripotency in Human Embryonic Stem Cells Is STAT3 Independent
Humphrey, R. K., Beattie, G. M., Lopez, A. D., Bucay, N., King, C. C., Firpo, M. T., Rose‐John, S., & Hayek, A. (2004) · STEM CELLS · doi:10.1634/stemcells.22-4-522 · Cited by 319
Self-citationFerreira, R. C., Freitag, D. F., Cutler, A. J., Howson, J. M. M., Rainbow, D. B., Smyth, D. J., Kaptoge, S., Clarke, P., Boreham, C., Coulson, R. M., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003444 · Cited by 316
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
Insights into Cytokine–Receptor Interactions from Cytokine Engineering
Spangler, J. B., Moraga, I., Mendoza, J. L., & Garcia, K. C. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120211 · Cited by 304
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522433 · Cited by 304
Self-citationAcquiring signalling specificity from the cytokine receptor gp130
Ernst, M. (2004) · Trends in Genetics · doi:10.1016/j.tig.2003.11.003 · Cited by 299
IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality
Zhang, H., Neuhöfer, P., Song, L., Rabe, B., Lesina, M., Kurkowski, M. U., Treiber, M., Wartmann, T., Regnér, S., Thorlacius, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64931 · Cited by 288
Self-citationExpression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini, C., Corbellino, M., Paulli, M., Magrini, U., Lazzarino, M., Moore, P. S., & Chang, Y. (1997) · Europe PMC (PubMed Central) · Cited by 286
Molden, J., Chang, Y., You, Y., Moore, P. S., & Goldsmith, M. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19625 · Cited by 280
The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.
Müllberg, J., Oberthür, W., Lottspeich, F., Mehl, E., Dittrich, E., Graeve, L., Heinrich, P. C., & Rose-John, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.4958 · Cited by 269
Self-citationNowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
Self-citationIL-6 Trans-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3
Greenhill, C. J., Rose-John, S., Lissilaa, R., Ferlin, W., Ernst, M., Hertzog, P. J., Mansell, A., & Jenkins, B. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002971 · Cited by 264
Self-citationOncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology
Hermanns, H. M. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.006 · Cited by 263
Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex
Chow, D.-C., He, X.-L., Snow, A. L., Rose-John, S., & Garcia, K. C. (2001) · Science · doi:10.1126/science.1058308 · Cited by 261
Self-citationKraakman, M. J., Kammoun, H. L., Allen, T. L., Deswaerte, V., Henstridge, D. C., Estevez, E., Matthews, V. B., Neill, B., White, D. A., Murphy, A. J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.006 · Cited by 257 · cited 1×
“Strikingly, selective blockade of IL-6 trans-signaling did not compromise host defense to mycobacteria (Sodenkamp et al. 2012), although infection was lethal in Il62/2 mice (Ladel et al. 1997).”
BackgroundSelf-citationJones, S. A., & Rose-John, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00319-1 · Cited by 255
Self-citationCLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex
Elson, G. C. A., Lelièvre, E., Guillet, C., Chevalier, S., Plun-Favreau, H., Froger, J., Suard, I., de Coignac, A. B., Delneste, Y., Bonnefoy, J.-Y., et al. (2000) · Nature Neuroscience · doi:10.1038/78765 · Cited by 252
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S., Jones, S. A., Rose-John, S., & Scheller, J. (2008) · Blood · doi:10.1182/blood-2007-07-102137 · Cited by 245
Self-citationTranssignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
Schuett, H., Oestreich, R., Waetzig, G. H., Annema, W., Luchtefeld, M., Hillmer, A., Bavendiek, U., von Felden, J., Divchev, D., Kempf, T., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.229435 · Cited by 243
Self-citationWunderlich, F. T., Ströhle, P., Könner, A. C., Gruber, S., Tovar, S., Brönneke, H. S., Juntti-Berggren, L., Li, L.-S., van Rooijen, N., Libert, C., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.011 · Cited by 229 · cited 2×
“…blockade of IL-6 trans-signaling prevented the inflammatory infiltration of macrophages into adipose tissue (Kraakman et al. 2015) without leading to increased insulin resistance or decreased glucose tolerance, which had been observed in IL-62/2 mice (Matthews et al. 2010; Wunderlich et al. 2010).”
BackgroundMolecular cloning and expression of hybridoma growth factor in Escherichia coli.
Brakenhoff, J. P. J., de Groot, E. R., Evers, R. F., Pannekoek, H., & Aarden, L. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4116 · Cited by 229
Pennica, D., Arce, V, Swanson, T. A., Vejsada, R., Pollock, R. A., Armanini, M., Dudley, K., Phillips, H. S., Rosenthal, A., Kato, A. C., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80281-0 · Cited by 220
Nowell, M. A., Williams, A. S., Carty, S. A., Scheller, J., Hayes, A. J., Jones, G. W., Richards, P. J., Slinn, S., Ernst, M., Jenkins, B. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.613 · Cited by 215
Self-citationMatsumoto, S., Hara, T., Mitsuyama, K., Yamamoto, M., Tsuruta, O., Sata, M., Scheller, J., Rose-John, S., Kado, S.-I., & Takada, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0801217 · Cited by 211
Self-citationUnraveling the Structure of IL-2
Bazan, J. F. (1992) · Science · doi:10.1126/science.1631562 · Cited by 202
Malik, N., Kallestad, J. C., Gunderson, N. L., Austin, S. D., Neubauer, M. G., Ochs, V, Marquardt, H., Zarling, J. M., Shoyab, M., & Wei, C. M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.7.2847 · Cited by 197
IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
Lo, C.-W., Chen, M.-W., Hsiao, M., Wang, S., Chen, C.-A., Hsiao, S.-M., Chang, J.-S., Lai, T.-C., Rose-John, S., Kuo, M.-L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1496 · Cited by 193
Self-citationJudd, L. M., Alderman, B. M., Howlett, M., Shulkes, A., Dow, C., Moverley, J., Grail, D., Jenkins, B. J., Ernst, M., & Giraud, A. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.066 · Cited by 180
Klouche, M., Bhakdi, S., Hemmes, M., & Rose-John, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4583 · Cited by 178
Self-citationBarkhausen, T., Tschernig, T., Rosenstiel, P., van Griensven, M., Vonberg, R.-P., Dorsch, M., Mueller-Heine, A., Chalaris, A., Scheller, J., Rose-John, S., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318211ff56 · Cited by 169
Self-citationNandurkar, H. H., Robb, L., Tarlinton, D., Barnett, L., Köntgen, F., & Begley, C. G. (1997) · Blood · doi:10.1182/blood.v90.6.2148 · Cited by 168
A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy
Tanaka, T., Narazaki, M., Ogata, A., & Kishimoto, T. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.009 · Cited by 164
Schumacher, N., Meyer, D., Mauermann, A., von der Heyde, J., Wolf, J., Schwarz, J., Knittler, K., Murphy, G., Michalek, M., Garbers, C., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.649509 · Cited by 162
Self-citationInterleukin (IL)-12 and IL-23 and Their Conflicting Roles in CancerPreprint
Yan, J., Smyth, M. J., & Teng, M. W. L. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028530 · Cited by 161
IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
Hoge, J., Yan, I., Jänner, N., Schumacher, V., Chalaris, A., Steinmetz, O. M., Engel, D. R., Scheller, J., Rose‐John, S., & Mittrücker, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201044 · Cited by 158
Self-citationGarbers, C., Monhasery, N., Aparicio-Siegmund, S., Lokau, J., Baran, P., Nowell, M. A., Jones, S. A., Rose-John, S., & Scheller, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.018 · Cited by 155
Self-citationRegulation of the acute phase and immune responses: interleukin-6.
Sehgal, P. B. (1989) · PubMed · Cited by 148
Yang, Z., Grote, D. M., Ziesmer, S. C., Manske, M. K., Witzig, T. E., Novak, A. J., & Ansell, S. M. (2011) · Blood · doi:10.1182/blood-2011-03-340885 · Cited by 147
Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited
Schuster, B., Kovaleva, M., Sun, Y. E., Regenhard, P., Matthews, V. B., Grötzinger, J., Rose‐John, S., & Kallen, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210044200 · Cited by 143
Self-citationMortier, E., Bernard, J., Plet, A., & Jacques, Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1681 · Cited by 143
Audet, J., Miller, C., Rose‐John, S., Piret, J. M., & Eaves, C. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1757 · Cited by 138
Self-citationProteolytic Cleavage Governs Interleukin-11 Trans-signaling
Lokau, J., Nitz, R., Agthe, M., Monhasery, N., Aparicio-Siegmund, S., Schumacher, N., Wolf, J., Möller‐Hackbarth, K., Waetzig, G. H., Grötzinger, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.053 · Cited by 137
Self-citationBrakenhoff, J. P. J., Hart, M. H. L., de Groot, E. R., Padova, F. D., & Aarden, L. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.2.561 · Cited by 135
Suthaus, J., Stuhlmann-Laeisz, C. M., Tompkins, V. S., Rosean, T. R., Klapper, W., Tosato, G., Janz, S., Scheller, J., & Rose‐John, S. (2012) · Blood · doi:10.1182/blood-2011-09-377705 · Cited by 135
Self-citationGarbers, C., Spudy, B., Aparicio-Siegmund, S., Waetzig, G. H., Sommer, J., Hölscher, C., Rose‐John, S., Grötzinger, J., Lorenzen, I., & Scheller, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432955 · Cited by 132
Self-citationCombined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration
Peters, M., Blinn, G., Jostock, T., Schirmacher, P., Büschenfelde, K. M. Z., Galle, P. R., & Rose–John, S. (2000) · Gastroenterology · doi:10.1053/gast.2000.20236 · Cited by 129
Self-citationGalun, E., Zeira, E., Pappo, O., Peters, M., & Rose-John, S. (2000) · The FASEB Journal · doi:10.1096/fj.99-0913com · Cited by 124
Self-citationIL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis
Brooks, G. D., McLeod, L., Alhayyani, S., Miller, A., Russell, P. A., Ferlin, W. G., Rose‐John, S., Ruwanpura, S. M., & Jenkins, B. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2388 · Cited by 122
Self-citationSTAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice
Mitsuyama, K., Matsumoto, S., Rose‐John, S., Suzuki, A., Hara, T., Tomiyasu, N., Handa, K., Tsuruta, O., Funabashi, H., Scheller, J., et al. (2006) · Gut · doi:10.1136/gut.2005.079343 · Cited by 121
Self-citationProtein kinase C activity is rate limiting for shedding of the interleukin-6 receptor
Müllberg, J., Schooltink, H., Stoyan, T., Heinrich, P. C., & Rose‐John, S. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92272-y · Cited by 118
Self-citationResponses to Cytokines and Interferons that Depend upon JAKs and STATsPreprint
Stark, G. R., Cheon, H., & Wang, Y. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028555 · Cited by 118
IL-6 Receptor Independent Stimulation of Human gp130 by Viral IL-6
Müllberg, J., Geib, T., Jostock, T., Hoischen, S. H., Vollmer, P., Voltz, N., Heinz, D. W., Galle, P. R., Klouche, M., & Rose‐John, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4672 · Cited by 111
Self-citationRichards, P. J., Nowell, M., Horiuchi, S., McLoughlin, R., Fielding, C., Grau, S., Yamamoto, N., Ehrmann, M., Rose-John, S., Williams, A., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21818 · Cited by 108
Self-citationOberg, H., Wesch, D., Grüssel, S., Rose‐John, S., & Kabelitz, D. (2006) · International Immunology · doi:10.1093/intimm/dxh396 · Cited by 103
Self-citationThe biology of interleukin-27 reveals unique pro- and anti-inflammatory functions in immunity
Aparicio-Siegmund, S., & Garbers, C. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.008 · Cited by 103
Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases
Egwuagu, C. E., Yu, C., Sun, L., & Wang, R. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.013 · Cited by 100
Lupardus, P. J., Skiniotis, G., Rice, A. J., Thomas, C., Fischer, S., Walz, T., & García, K. C. (2011) · Structure · doi:10.1016/j.str.2010.10.010 · Cited by 95
Viswanathan, S., Benatar, T., Rose‐John, S., Lauffenburger, D. A., & Zandstra, P. W. (2002) · Stem Cells · doi:10.1634/stemcells.20-2-119 · Cited by 93
Self-citationInflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN
Luig, M., Kluger, M. A., Goerke, B., Meyer, M. C., Nosko, A., Yan, I., Scheller, J., Mittrücker, H., Rose‐John, S., Stahl, R. A. K., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014060620 · Cited by 83
Self-citationKeupp, K., Li, Y., Vargel, İ., Hoischen, A., Richardson, R. J., Neveling, K., Alanay, Y., Uz, E., Elcioglu, N. H., Rachwalski, M., et al. (2013) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.28 · Cited by 80
Sodenkamp, J., Waetzig, G. H., Scheller, J., Seegert, D., Grötzinger, J., Rose‐John, S., Ehlers, S., & Hölscher, C. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.01.015 · Cited by 68
Self-citationDesbois, M., Vu, P. L., Coutzac, C., Marcheteau, E., Béal, C., Terme, M., Gey, A., Morisseau, S., Teppaz, G., Boselli, L., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600019 · Cited by 65
IL-6 Trans-Signaling Drives Murine Crescentic GN
Braun, G. S., Nagayama, Y., Maruta, Y., Heymann, F., van Roeyen, C. R. C., Klinkhammer, B. M., Boor, P., Villa, L., Salant, D. J., Raffetseder, U., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111147 · Cited by 61
Self-citationRousseau, F., Gauchat, J., McLeod, J. G., Chevalier, S., Guillet, C., Guilhot, F., Cognet, I., Froger, J., Hahn, A. F., Knappskog, P. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509598103 · Cited by 61
Interleukin‐6 Trans‐Signaling Exacerbates Inflammation and Renal Pathology in Lupus‐Prone Mice
Tsantikos, E., Maxwell, M. J., Putoczki, T. L., Ernst, M., Rose‐John, S., Tarlinton, D. M., & Hibbs, M. L. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38061 · Cited by 56
Self-citationWei, L., Chou, C., Chen, M., Rose‐John, S., Kuo, M., Chen, S., & Yang, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3462 · Cited by 56
Self-citationPflanz, S., Tacken, I., Grötzinger, J., Jacques, Y., Dahmen, H., Heinrich, P. C., & Müller‐Newen, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00477-9 · Cited by 55
Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?
Febbraio, M. A., Rose‐John, S., & Pedersen, B. K. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.1 · Cited by 55
Self-citationRuwanpura, S. M., McLeod, L., Dousha, L. F., Seow, H. J., Alhayyani, S., Tate, M. D., Deswaerte, V., Brooks, G. D., Bozinovski, S., MacDonald, M., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2368oc · Cited by 55
Self-citationThe soluble interleukin-6 receptor and related proteins
Rose‐John, S. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.07.001 · Cited by 51
Self-citationSafety issues and concerns of new immunomodulators in rheumatology
Selmi, C. F., Ceribelli, A., Naguwa, S. M., Cantarini, L., & Shoenfeld, Y. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.993605 · Cited by 48
Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization
Suthaus, J., Adam, N., Grötzinger, J., Scheller, J., & Rose‐John, S. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.10.016 · Cited by 41
Self-citationRose‐John, S., Scheller, J., & Schaper, F. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.011 · Cited by 31
Self-citationMolecular Cloning of the cDNAs for Interleukin‐6/B Cell Stimulatory Factor 2 and Its Receptora
Hirano, T., Taga, T., Yamasaki, K., Matsuda, T., Yasukawa, K., HIRATA, Y., Yawata, H., Tanabe, O., Akira, S., & Kishimoto, T. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24010.x · Cited by 29
März, P., Özbek, S., Fischer, M., Voltz, N., Otten, U., & Rose-John, S. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02977.x · Cited by 18
Self-citation
Cited by
Cytokines in Inflammatory Disease
Kany, S., Vollrath, J. T., & Relja, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236008 · Cited by 1,971
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Harnessing cytokines and chemokines for cancer therapy
Propper, D. J., & Balkwill, F. R. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00588-9 · Cited by 989
Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review
Di Gennaro, F., Pizzol, D., Marotta, C., Antunes, M., Racalbuto, V., Veronese, N., & Smith, L. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17082690 · Cited by 822
Interleukins in cancer: from biology to therapy
Briukhovetska, D., Dörr, J., Endres, S., Libby, P., Dinarello, C. A., & Kobold, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00363-z · Cited by 781
Metadata
- Authors
- Rose-John, S.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-06-15
- Volume
- 10
- Issue
- 2
- Pages
- a028415
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2626842659
- Cited by
- 799
- References
- 127
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.